Skip to content

AcrySof™ IQ PanOptix™ Toric UV IOL TFAT30 (REF TFAT30.165)Recalls & reported problems

Alcon Laboratories, Inc. · AcrySof® IQ PanOptix® Toric Trifocal intraocular lenses (IOLs) are ultraviolet absorbing foldable multifocal IOLs · Class 3 · Implant

All models of AcrySof IQ PanOptix Toric UV IOL (120)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
6
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00380652418638), received between Apr 23, 2021 and May 1, 2024 — classified as 6 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem6

Patient problems

  • Visual Impairment4
  • Blurred Vision2
  • Halo2
  • Insufficient Information1
  • Visual Disturbances1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 1, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED VA FLUX, CLOUDY VA, UNCLEAR AND CLINICAL REASON FOR EXPLANT BEING SUBJECTIVE VISUAL DISTURBANCE. THE IOL WAS EXPLANTED AND EXCHANGED FOR AN UNKNOWN ATIOL FOLLOWING THE INITIAL IMPLANT PROCEDURE. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND RECEIVED STATING THAT PT UNDERWENT A YAG IN JAN 2023 AND THE LASIK MARCH OF 2023 IN THE LEFT EYE AFTER THE INITIAL IMPLANT. THESE PROCEDURES WERE DONE TO SEE IF THEY WOULD ALLEVIATE PATIENTS COMPLAINTS WITH HER LEFT EYE, AFTER MUCH CONSIDERATION, IT WAS AGREED UPON THAT AN IOL EXCHANGE TO A MONOFOCAL IOL WAS HER BEST OPTION. IN THE SURGEON'S OPINION WHAT CAUSED THE EVENT WAS SUBJECTIVE VISUAL CONCERNS, PATIENTS VISUAL ACUITY WAS GREAT, SHE JUST COULDN'T ADJUST TO THE MODALITY OF THE MULTIFOCAL. LENS WAS EXCHANGED WITH A NON COMPANY LENS. SYMPTOMS RESOLVED. SURGEON'S PROGNOSIS WAS, SO FAR SHE'S ONLY BEEN SEEN ON 4/3 FOR THE 1 DAY POST OP, HEALING WELL, BUT NOT ENOUGH INFO YET.

    Patient problems: Visual Impairment

    MAUDE report 19221980 ↗
  • InjuryMay 22, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A NON HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED GLARE, HALOS AND NO CONTRAST . THE IOL WAS EXCHANGED FOR ANOTHER LENS MODEL 18 MONTHS FOLLOWING THE INITIAL IMPLANT PROCEDURE. THE CLINICAL REASON FOR EXPLANT MENTIONED AS UNACCEPTABLE QUALITY OF VISION DUE TO GLARE, HALOS, NO CONTRAST . ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Halo; Visual Disturbances; Visual Impairment

    MAUDE report 16972557 ↗
  • InjuryMar 3, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A NON-HEALTHCARE PROFESSIONAL REPORTED FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT COMPLAINED OF VISION UNCLEAR AT ALL RANGES AND CAN¿T READ. THE LENS WAS EXPLANTED AND REPLACED WITH ANOTHER LENS IN A SECONDARY PROCEDURE. THERE WAS NO PATIENT HARM AND PATIENT WAS NOT HOSPITALIZED AS A RESULT OF THIS EVENT. ADDITIONAL INFORMATION WAS REQUESTED, BUT FURTHER NO INFORMATION WAS AVAILABLE.

    Patient problems: Blurred Vision

    MAUDE report 16476270 ↗
  • InjuryJul 12, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A FACILITY REPRESENTATIVE REPORTED THAT 50 DAYS FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE IOL WAS EXCHANGED FOR ANOTHER LENS DUE TO A REFRACTIVE ERROR AND NOT ABLE TO SEE WELL.

    Patient problems: Visual Impairment

    MAUDE report 12148651 ↗
  • InjuryMay 7, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PHYSICIAN REPORTED AN EXPLANTED INTRAOCULAR LENS FOR A PATIENT. ADDITIONAL INFORMATION WAS RECEIVED REPORTING THAT IN THE SURGEON¿S OPINION, THE PRODUCT CAUSE OR CONTRIBUTE TO THE EVENT.

    Patient problems: Insufficient Information

    MAUDE report 11789674 ↗
  • InjuryApr 23, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A CUSTOMER REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED BLURRY VISION, GLARE AND HALOS. DESCRIBED VISION AS "LIKE LOOKING THROUGH A BOTTLE". THE IOL WAS EXCHANGED FOR ANOTHER LENS APPROXIMATELY TWO MONTHS AFTER THE INITIAL IMPLANTATION. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Blurred Vision; Halo; Visual Impairment

    MAUDE report 11712790 ↗

Other Lens, multifocal intraocular devices

All Lens, multifocal intraocular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page